EBF
EBF Focus

SPRING 2021: EBF Cyberconnect meetings

Due to anticipated continued COVID-19 travel restrictions,
the EBF will host 4 interactive training days / workshops in Spring 2021.
Click on below tabs to see the details of each meeting

 

Spotlight on  (Ligand Binding & cell-based Assays and Automation)  TECHNOLOGY 

On 20 and 21 May, the 3rd EBF Cyberconnect Event in 2021 will focus on Ligand Binding & cell-based Assays and Automation Technology.

CALL FOR SPEAKERS

The call for speakers in closed

MEETING AGENDA

Considering the submitted abstract, supplemented with experts we invited to present at the workshop, we have built an exciting program. The see the final version of the agenda: download this PDF

Each session will include a combination of plenary presentations, case studies and Q&A moments. On day 1, an interactive round table will discuss the challenges of bringing new platforms for NBEs into the regulatory space.

WHO SHOULD ATTEND?

Scientists and managers from Pharma R&D, CRO, Academia, technology providers and Health Authorities with passion for science and new technologies, regulatory challenges and automation.

CALL FOR REGISTRATION 

Registration is closed.

Organising Committee:

Organising Committee: : Matthew Barfield (Roche), Anna Laurén (Novo Nordisk), Robert Nelson (Covance), Johannes Stanta (Freeline Therapeutics) and Philip Timmerman (EBF)